Company / Current Liabilities
CG Oncology, Inc. Current Liabilities History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$30.8M
FY2025
5-year range
$14.3M / $30.8M
FY2023-FY2025
Trend
+44.3%
vs FY2024
Sector context
#174 of 213
Health Care
What the data says
CG Oncology, Inc.'s current liabilities of $31M is lower than 82% of companies in the Health Care sector (FY2025). Increased from $14M to $31M over the past 2 years.
Based on SEC 10-K filings.
$31M in FY2025.
Increased from $14M to $31M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 213This company $30.8M Sector average $1.6B
▼
-98.1% below sector average
Key checks
Key Insights
- In FY2025, current liabilities increased 44.3% year-over-year.
- Ranks #174 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $30.8M | +44.3% |
| FY2024 | $21.4M | +49.9% |
| FY2023 | $14.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026